Responsiveness of the EuroQol 5‐Dimension 3‐Level instrument, Dermatology Life Quality Index ( DLQI ) and DLQI ‐Relevant for patients with psoriasis in the U.S.A.
- 6 August 2019
- journal article
- letter
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 181 (5), 1088-1090
- https://doi.org/10.1111/bjd.18142
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (1P30AR069589‐01)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32‐AR‐007465)
This publication has 7 references indexed in Scilit:
- Time to revise the Dermatology Life Quality Index scoring in psoriasis treatment guidelinesJournal of the European Academy of Dermatology and Venereology, 2019
- Evaluation of the Dermatology Life Quality Index scoring modification, the DLQI‐R score, in two independent populationsBritish Journal of Dermatology, 2018
- Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasisBritish Journal of Dermatology, 2018
- Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers A Randomized Placebo-Controlled TrialCirculation: Cardiovascular Imaging, 2018
- Dermatology Life Quality Index: Time to Move ForwardJournal of Investigative Dermatology, 2012
- The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II studyHealth and Quality of Life Outcomes, 2006
- Comparative responsiveness of generic and specific quality-of-life instrumentsJournal of Clinical Epidemiology, 2003